ClinicalMetric / Countries / Switzerland
← All Countries
🇨🇭
COUNTRY FEED

Clinical Trials in Switzerland

Active recruiting clinical trials with sites in Switzerland. Select a condition below to see detailed trial listings.

Total Trials: 178 // Recruiting: 178 // Updated: Daily

Switzerland currently has 178 clinical trials with at least one registered site in the country, of which 178 are actively recruiting participants. The most studied conditions at Switzerland sites are Coronary Artery Disease, Hypertension, Quality of Life, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Insel Gruppe AG, University Hospital Bern, University Hospital, Basel, Switzerland, University of Zurich. By stage, active Switzerland trials break down as Phase 1 (8), Phase 2 (16), Phase 3 (9), Phase 4 (4). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Switzerland

Coronary Artery Disease 4 Hypertension 3 Quality of Life 3 Lung Cancer 3 Healthy 2 Spinal Cord Injuries 2 Nociceptive Pain 2 Aging 2 Liver Diseases 2 Spinal Cord Injuries (SCI) 2 Venous Thromboembolism (VTE) 2 Postpartum 2 Colorectal Cancer 2 Dyspnea 2 Stroke 2 Self Efficacy 2 Cancer 2 Parkinson's Disease 2 Mild Cognitive Impairment 2 Incisional Hernia 2
All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇮🇹Italy 🇪🇸Spain 🇬🇧United Kingdom 🇳🇱Netherlands 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology